Related Experiment Video
Updated: Aug 18, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
Published on: May 10, 2016
[Childhood poisoning: data from the French Poison Control and Toxicovigilance Centres (2002)]
Gaëtan Guyodol1, Vincent Danel
1Centre antipoison et de toxicovigilance, Hôpital Fernand Widal, Paris, France. gaetan.guyodo@lrb.ap-hop-paris.fr
Materials And Methods:
Data for 2002 from a number of French poison control centres were analysed in terms of several age groups; 87 678 possible or established poisoning cases were counted, including 49 355 cases in the 0- to 18-year age group.
Results:
The 0- to 3-year age group accounted for 71.7% of cases of childhood poisoning. Accidental poisoning was predominant up to 12 years, while from 13 to 18 years poisoning was essentially deliberate. The principal route of exposure was oral and involved liquids for babies and solid products for older children. The toxic agents most often implicated were pharmaceuticals and domestic products. The place of poisoning was mainly the home. A 'no-risk' evaluation was performed, and varied between 41.6% before the age of 3 years to 18.0% for the 13- to 18-year age group. The oldest children were more often managed in medical facilities.
Discussion:
Fortunately, most of these poisoning cases were not serious (death rate: 0.026%). The poison control centres' information system is continuing to expand: it will allow an improvement in medical health monitoring associated with poisoning.
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Prevention of Further Absorption of Poison
Pharmaceutical Poisoning: Treatment Strategies
Drug Toxicity: Risk factors
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
